Deprecated: abs(): Passing null to parameter #1 ($num) of type int|float is deprecated in /home/individends/public_html/financial_analysis.php on line 303

Profitability Metrics

Gross Margin
213.00%
Operating Margin
350.93%
Net Margin
349.55%

Efficiency Metrics

Revenue per Expense Ratio
-0.40
R&D as % of Revenue
0.00%

Earnings Quality

EBITDA Margin
92.34%
Income Tax Rate
52,300,000.0%
EPS
-1.7000000000

Balance Sheet Analysis

Current Ratio
0.31
Cash Ratio
0.43
Working Capital
$-116.43M
Debt to Equity
4.31
Debt to Assets
79.14%
Equity Ratio
18.34%

Cash Flow Analysis

Operating Cash Flow Ratio
-408.47%
Free Cash Flow Ratio
-408.47%
CapEx to Revenue
0.00%
Dividends Paid
$31.21M
Stock Buybacks
No buybacks
Total Shareholder Returns
$31.21M
Cash Position Change
5.76%

Key Takeaways (2023 FY)

  • Revenue declined by 124.76550643147%, indicating potential market challenges
  • Increased R&D investment by 100.00%

Detailed Growth Metrics

Core Performance

Revenue
-124.77%
Net Income
-260.05%
EPS
-254.55%
Operating Income
-177.93%

Operational Efficiency

R&D Expenses
100.00%
SG&A Expenses
117.76%
Operating Cash Flow
-32.14%
Free Cash Flow
85.85%

Balance Sheet Health

Assets
-1.12%
Debt
499.47%
Book Value per Share
-26.75%
Inventory
-100.00%

Shareholder Returns

Dividends per Share
-23.77%
Shares Outstanding
32.85%

Long Term Trends

3Y Revenue/Share
88.82%
5Y Revenue/Share
-111.32%
3Y Dividend/Share
-37.88%
5Y Dividend/Share
-54.03%